Immuneering (IMRX) Short Interest Ratio & Short Volume → You need to know these two things about AI stocks ASAP… (From InvestorPlace) (Ad) Free IMRX Stock Alerts $1.65 +0.01 (+0.61%) (As of 05/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Immuneering Short Interest DataCurrent Short Volume2,730,000 sharesPrevious Short Volume2,880,000 sharesChange Vs. Previous Month-5.21%Dollar Volume Sold Short$5.23 millionShort Interest Ratio / Days to Cover4.0Last Record DateApril 15, 2024Outstanding Shares29,650,000 sharesFloat Size20,630,000 sharesShort Percent of Float13.23%Today's Trading Volume315,097 sharesAverage Trading Volume526,954 sharesToday's Volume Vs. Average60% Short Selling Immuneering ? Sign up to receive the latest short interest report for Immuneering and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIMRX Short Interest Over TimeIMRX Days to Cover Over TimeIMRX Percentage of Float Shorted Over Time Ad InvestorPlaceThis is the ONLY AI story you should be worried aboutA.I. is creeping into every aspect of our daily lives… According to billion-dollar fund manager, Louis Navellier, it’s never been more important to A.I.-proof your wealth. He lays out three simple steps to take ASAP in his latest video.Click here to watch it now. Immuneering Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,730,000 shares $5.23 million -5.2%13.2%4 $1.92 3/31/20242,880,000 shares $8.32 million +10.3%14.0%4.8 $2.89 3/15/20242,610,000 shares $4.99 million -2.6%12.4%5.1 $1.91 2/29/20242,680,000 shares $16.62 million -0.7%12.6%40.4 $6.20 2/15/20242,700,000 shares $18.09 million +1.1%12.7%47.3 $6.70 1/31/20242,670,000 shares $15.67 million +1.1%12.6%42.4 $5.87 Get the Latest News and Ratings for IMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immuneering and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,640,000 shares $17.42 million +0.4%12.5%40.2 $6.60 12/31/20232,630,000 shares $19.33 million +3.5%12.4%39.6 $7.35 12/15/20232,540,000 shares $20.32 million -1.2%12.0%39.3 $8.00 11/30/20232,570,000 shares $16.86 million -6.9%12.1%43 $6.56 11/15/20232,760,000 shares $14.57 million -1.1%13.0%48.4 $5.28 10/31/20232,790,000 shares $19.61 million +1.8%13.2%58.2 $7.03 10/15/20232,740,000 shares $16.44 million -1.1%12.9%55.5 $6.00 9/30/20232,770,000 shares $21.27 million -2.5%13.1%54.7 $7.68 9/15/20232,840,000 shares $22.86 million +1.4%13.4%47.3 $8.05 8/31/20232,800,000 shares $25.23 million No Change13.2%27.5 $9.01 8/15/20232,800,000 shares $26.29 million +5.3%13.2%25.2 $9.39 7/31/20232,660,000 shares $27.03 million -0.8%12.6%23.6 $10.16 7/15/20232,680,000 shares $26.53 million +0.4%12.7%23 $9.90 6/30/20232,670,000 shares $27.07 million +35.5%12.6%21.7 $10.14 6/15/20231,970,000 shares $19.40 million +8.2%9.3%16.4 $9.85 5/31/20231,820,000 shares $14.11 million +15.9%8.6%23.9 $7.75 5/15/20231,570,000 shares $12.53 million +25.6%7.4%24 $7.98 4/30/20231,250,000 shares $13.73 million +23.8%6.3%19.5 $10.98 4/15/20231,010,000 shares $12.71 million +6.1%5.0%17.8 $12.58 3/31/2023951,600 shares $9.24 million +10.2%5.0%19.7 $9.71 3/15/2023863,500 shares $6.71 million +4.1%4.5%19.5 $7.77 2/28/2023829,300 shares $4.06 million +0.2%4.3%20.5 $4.89 2/15/2023828,000 shares $3.52 million -0.6%4.3%20.5 $4.25 1/31/2023832,900 shares $3.49 million -2.9%4.3%19 $4.19 1/15/2023857,900 shares $3.80 million -1.6%4.5%21.4 $4.43 12/30/2022871,800 shares $4.23 million -1.2%4.6%19.2 $4.85 12/15/2022882,600 shares $4.03 million +7.0%4.6%16.9 $4.57 11/30/2022825,200 shares $5.36 million +6.2%4.3%15.2 $6.49 11/15/2022776,800 shares $5.62 million -6.0%4.1%14.3 $7.24 10/31/2022826,200 shares $11.44 million +1.6%4.3%16.6 $13.85 10/15/2022813,500 shares $10.46 million +0.9%4.2%17.5 $12.86 9/30/2022806,000 shares $11.54 million +9.1%4.2%18.7 $14.32 9/15/2022738,600 shares $8.86 million -2.5%3.9%10.6 $11.99 8/31/2022757,700 shares $4.23 million -3.3%4.0%10.5 $5.58Controversial CEO explains new way to amass wealth (Ad)There's no shortage of controversial CEOs in America today... From Elon Musk... to Disney's Bob Iger... to JP Morgan's Jamie Dimon... But only one controversial CEO that I know of is willing to show you exactly how and why he cut his annual salary to $1...Don't miss Porter's brand-new presentation on this subject IMRX Short Interest - Frequently Asked Questions What is Immuneering's current short interest? Short interest is the volume of Immuneering shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 2,730,000 shares of IMRX short. 13.23% of Immuneering's shares are currently sold short. Learn More on Immuneering's current short interest. What is a good short interest ratio for Immuneering? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMRX shares currently have a short interest ratio of 4.0. Learn More on Immuneering's short interest ratio. What is a good short interest percentage for Immuneering? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.23% of Immuneering's floating shares are currently sold short. Is Immuneering's short interest increasing or decreasing? Immuneering saw a decline in short interest in April. As of April 15th, there was short interest totaling 2,730,000 shares, a decline of 5.2% from the previous total of 2,880,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Immuneering's float size? Immuneering currently has issued a total of 29,653,000 shares. Some of Immuneering's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Immuneering currently has a public float of 20,630,000 shares. How does Immuneering's short interest compare to its competitors? 13.23% of Immuneering's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Immuneering: Bolt Biotherapeutics, Inc. (8.63%), Rapid Micro Biosystems, Inc. (0.33%), Rockwell Medical, Inc. (2.40%), Cara Therapeutics, Inc. (5.62%), Lexaria Bioscience Corp. (3.70%), Ocuphire Pharma, Inc. (6.17%), Unicycive Therapeutics, Inc. (1.53%), Xilio Therapeutics, Inc. (4.35%), Apollomics, Inc. (0.32%), ProMIS Neurosciences, Inc. (0.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Immuneering stock? Short selling IMRX is an investing strategy that aims to generate trading profit from Immuneering as its price is falling. IMRX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Immuneering? A short squeeze for Immuneering occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMRX, which in turn drives the price of the stock up even further. How often is Immuneering's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMRX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Bolt Biotherapeutics Short Interest Rapid Micro Biosystems Short Interest Rockwell Medical Short Interest Cara Therapeutics Short Interest Lexaria Bioscience Short Interest Ocuphire Pharma Short Interest Unicycive Therapeutics Short Interest Xilio Therapeutics Short Interest Apollomics Short Interest ProMIS Neurosciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMRX) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin Analytics